Blood markers in diabetic kidney disease
Part of Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study looks at certain blood markers (immune system and platelets) in people with diabetic kidney disease compared to healthy people. It may help doctors better understand and manage diabetes-related kidney damage.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 80 years old.
- You must have a confirmed diagnosis of type 2 diabetes.
- You must not have type 1 diabetes.
- You must not have an active infection or signs of inflammation at the time of the test.
- You must not have any chronic inflammatory or autoimmune diseases (e.g., rheumatoid arthritis, lupus), chronic liver disease, or non-diabetic kidney disease (e.g., nephrotic syndrome).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the bacteria in your gut and certain substances in your blood might affect blood sugar changes and kidney health in people with diabetic kidney disease. If you have type 2 diabetes and kidney issues, this trial could help find better ways to track your condition.
This study looks at how common diabetic kidney damage is in people with type 2 diabetes, and which factors can predict it. If you qualify, you may be asked to have a kidney biopsy to understand what’s happening inside your kidneys.
This study looks at people with type 2 diabetes who have kidney problems and relates their symptoms and lab findings to what is seen on kidney biopsy. It may help doctors better understand what is driving kidney damage in diabetes.
This study looks at how the immune system works in people with diabetic kidney disease. It tests whether certain blood pressure medicines can help protect the kidneys.
This trial is developing and checking a new technique to detect early diabetic nephropathy, which means early damage to the kidneys caused by diabetes. It may help people catch kidney problems sooner, so treatment can start earlier.
This study is testing two new blood tests (cathepsin S and chromogranin A) to see if they can detect early kidney damage in people with type 2 diabetes. It may help doctors find kidney problems sooner.
Hear when a new Diabetic Kidney Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.